Skip to main content
. 2021 Oct 19;12:762548. doi: 10.3389/fendo.2021.762548

Figure 3.

Figure 3

The recurrence-free survival (primary tumor size <5 versus primary tumor size ≥5cm, average Ki-67 count <3% versus Ki-67 count ≥3%) in pheochromocytoma patients.